Aurobindo Pharma Ltd. (AUROPHARM): Aurobindo Pharma Share Price rises 2.56% near 52-week high on Rs 95,794.67 crore market cap

Aurobindo Pharma Share Price opened the session at Rs 1,626.75 and last traded at Rs 1,683, up Rs 42 or 2.56% from the previous close of Rs 1,641. The move kept the stock close to its 52-week high of Rs 1,685.7, while market capitalisation stood at Rs 95,794.67 crore. According to latest Univest figures, the stock is being tracked as a near 52-week high event rather than a record-break event, and the price action is relevant because it places AUROPHARM near a fresh yearly reference point without implying any company-specific trigger.

The latest Univest data confirms the stock news today is centered on the price move itself, the narrow distance to the yearly high and the valuation backdrop in the Healthcare sector. For readers tracking Aurobindo Pharma Share Price Today, the important question is not only where the share price is trading, but also how the current numbers compare with its earnings, book value and industry benchmark. Univest is also useful here because it puts the live quote, ratio snapshot and peer context in one place for Aurobindo Pharma Share Price analysis.

Aurobindo Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,683
Previous Close	Rs 1,641
Today's Move	+Rs 42 (+2.56%)
Open	Rs 1,626.75
High	Rs 1,685.7
Low	Rs 1,626.75
Turnover	Rs 0.77 crore
Market Capitalisation	Rs 95,794.67 crore

Aurobindo Pharma Ltd. (AUROPHARM) traded at Rs 1,683 versus the previous close of Rs 1,641, a rise of 2.56%. The stock opened at Rs 1,626.75, reached a high of Rs 1,685.7 and touched a low of Rs 1,626.75.

Aurobindo Pharma Share Price Today was supported by a gap between the previous close of Rs 1,641 and the last traded price of Rs 1,683. The stock moved within a day range of Rs 1,626.75 to Rs 1,685.7, and turnover stood at Rs 0.77 crore. The close proximity to the 52-week high of Rs 1,685.7 means the stock is trading just below that yearly high reference, while the day’s range shows that the price stayed near the upper end of the session band.

What exactly happened today is straightforward: AUROPHARM moved higher in percentage terms and remained close to its one-year high without crossing it. That makes Aurobindo Pharma Share Price a notable item in stock market today searches and in stocks in news lists, especially for readers following share market today moves in the healthcare space. The latest Aurobindo Pharma Stock News is therefore price-led, not event-led, and the verified data confirms the price event without establishing a company-specific catalyst. Univest continues to track such share price update moves as part of broader market news coverage.

Aurobindo Pharma Ltd. (AUROPHARM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 95,794.67 crore
P/E Ratio	25.43x
P/B Ratio	2.43x
ROE	9.93%
ROCE	12.76%
EPS	Rs 64.52
Book Value Per Share	Rs 676.49
Dividend Yield	0.24%

Aurobindo Pharma Ltd. (AUROPHARM) fundamental metrics show P/E 25.43x, P/B 2.43x, ROE 9.93%, ROCE 12.76%. These figures provide context only and are not a buy or sell signal.

Aurobindo Pharma Ltd. has a market capitalisation of Rs 95794.67 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.43x, P/B at 2.43x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.93% and ROCE of 12.76%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 64.52, book value per share of Rs 676.49, dividend yield of 0.24%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	25.43x
Benchmark Median P/E	28.19x
Benchmark Average P/E	40.48x
Benchmark P/E Range	0x to 661.74x
Company P/B Ratio	2.43x
Benchmark Median P/B	2.98x
Company ROE	9.93%
Benchmark Median ROE	11.78%
Company ROCE	12.76%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 95,794.67 crore
Benchmark Median Market Cap	Rs 730.86 crore

Aurobindo Pharma Ltd. (AUROPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Aurobindo Pharma Ltd. (AUROPHARM) has a P/E ratio of 25.43x, which is below the benchmark median of 28.19x, a difference of -9.79%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Aurobindo Pharma Ltd. (AUROPHARM) has a ROE of 9.93%, which is below the benchmark median of 11.78%, a difference of -15.7%. Aurobindo Pharma Ltd. (AUROPHARM) has a ROCE of 12.76%, which is below the benchmark median of 13.65%, a difference of -6.52%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dr. Reddy's Laboratories Ltd.	DRREDDY	95,967.37	29.67	2.5	11.69	13.75
Mankind Pharma Ltd.	MANKIND	94,531.56	45.46	5.52	12.69	13.24
Lupin Ltd.	LUPIN	93,984.14	16.93	3.93	27.11	28.86
Laurus Labs Ltd.	LAURUSLABS	1,03,902.04	94.19	18.26	18.31	18.2
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,09,625.67	24.42	4.09	19.69	21.39

Aurobindo Pharma Ltd. (AUROPHARM) has a P/E ratio of 25.43x compared with the displayed peer median of 29.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.93% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 12.76% versus the displayed peer median of 18.2%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARM) has a market capitalisation of Rs 95,794.67 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Aurobindo Pharma

• Aurobindo Pharma Share Price last traded at Rs 1,683, which is close to its 52-week high of Rs 1,685.7.
• The stock rose Rs 42, or 2.56%, from the previous close of Rs 1,641.
• Market capitalisation stood at Rs 95,794.67 crore.
• P/E ratio was 25.43 and P/B ratio was 2.43.
• Revenue for Jun 2026 was Rs 91,503.5 crore and net profit for Jun 2026 was Rs 10,325.6 crore.

About Aurobindo Pharma

Aurobindo Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For readers following Aurobindo Pharma Share Price, that classification is the core company context available in the latest Univest profile. The stock is listed on NSE and BSE under the symbol AUROPHARM, and the current market view is shaped by price action, valuation ratios and sector benchmarking rather than a separate company description. Univest presents Aurobindo Pharma Share Price, Aurobindo Pharma Stock News and Aurobindo Pharma Share Price Today together so readers can review the quoted price and business context in one place.

Frequently Asked Questions

Why is Aurobindo Pharma Share Price in focus today?

Ans. Aurobindo Pharma Share Price is in focus because it traded at Rs 1,683, up 2.56%, and remained close to its 52-week high of Rs 1,685.7. Market capitalisation stood at Rs 95,794.67 crore.

What is Aurobindo Pharma Share Price today?

Ans. Aurobindo Pharma Share Price today was Rs 1,683 at the latest trade. It moved up from the previous close of Rs 1,641 and stayed within a narrow range near the yearly high reference.

How far is Aurobindo Pharma from its 52-week high?

Ans. Aurobindo Pharma Share Price was just below its 52-week high of Rs 1,685.7. The latest trade at Rs 1,683 placed it very close to that level without crossing it.

What does Aurobindo Pharma Share Price tell investors today?

Ans. Aurobindo Pharma Share Price today shows a stock trading near its one-year high while also carrying a market cap of Rs 95,794.67 crore, a P/E of 25.43 and a P/B of 2.43.

Is Aurobindo Pharma expensive compared with its industry?

Ans. Aurobindo Pharma’s P/E of 25.43 is below the industry median of 28.19 and below the average of 40.48. Its P/B of 2.43 is also below the industry median of 2.98.

How do Aurobindo Pharma earnings and revenue compare?

Ans. Revenue for Jun 2026 was Rs 91,503.5 crore, higher than Rs 78,681.4 crore in Jun 2025.5 crore in Jun 2025.

What are the key valuation metrics for Aurobindo Pharma?

Ans. The key valuation metrics are P/E at 25.43, P/B at 2.43, EPS at Rs 64.52, book value per share at Rs 676.49 and dividend yield at 0.24%. These define the current valuation snapshot.

Where does Aurobindo Pharma stand versus peers?

Ans. Aurobindo Pharma’s market cap is close to Dr. Reddy’s and Mankind Pharma, below Zydus Lifesciences, and its P/E is below Dr. Reddy’s and Mankind Pharma but above Lupin.

Track Aurobindo Pharma Share Price on Univest

Use Aurobindo Pharma Ltd. (AUROPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Aurobindo Pharma Share Price on Univest for live share price updates, company financials, valuation ratios, 52-week levels, market capitalisation, sector comparison and related stock news. Univest also brings together Aurobindo Pharma Share Price Today, Aurobindo Pharma Latest News and Aurobindo Pharma Stock Analysis in a single view for easier monitoring.